SEARCH:   Advanced

Blood, 3 September 2009, Vol. 114, No. 10, pp. 2007-2008. This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via CrossRef Google Scholar Articles by Dimopoulos, M.-A. Articles by Terpos, E. PubMed PubMed Citation Articles by Dimopoulos, M.-A. Articles by Terpos, E. Related Collections Related Article in Blood Online Social Bookmarking                   What's this? Next Article  CLINICAL TRIALS Comment on Bartel et al, page 2068 A new pet for myeloma Meletios-Athanassios Dimopoulos, Lia A. Moulopoulos, and Evangelos Terpos UNIVERSITY OF ATHENS Abstract In this issue of Blood, Bartel and colleagues report the independent predictive value of the PET/CT and of the FDG suppression before transplantation in newly diagnosed myeloma patients who were treated using the TT3 regimen.1 CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? Related Article in Blood Online: F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma Twyla B. Bartel, Jeff Haessler, Tracy L. Y. Brown, John D. Shaughnessy, Jr, Frits van Rhee, Elias Anaissie, Terri Alpe, Edgardo Angtuaco, Ronald Walker, Joshua Epstein, John Crowley, and Bart Barlogie Blood 2009 114: 2068-2076. [Abstract] [Full Text] [PDF]

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020